Published in Vaccine Weekly, November 21st, 2007
"Dr. Yamshchikov has an impressive combination of scientific, technical and regulatory expertise, with more than 20 years experience with research in molecular virology in BSL-3 and ABSL-3 laboratories," said William R. Waud, Ph.D., interim vice president of the Drug Development Division at Southern Research. "His...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-11-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.